New Podcast Episode: Behind Pharma’s Reputation with Ray Jordan

In the latest episode of the Future of Pharma, host Samir Gondalia, is joined by a true heavyweight in corporate affairs and reputation strategy—Ray Jordan, Principal at Putnam Insights.

Ray’s career spans some of the most influential companies in healthcare and biotech, including Moderna, Amgen, Johnson & Johnson, and Pfizer. With decades of experience helping organizations navigate public perception, Ray has been repeatedly recognized by industry leaders like PRWeek and PRovoke Media for his exceptional work in reputational growth.

In this candid and wide-ranging conversation, we dive deep into the challenges and strategies behind managing public trust in the pharmaceutical industry. Topics we explore include:

• What an image crisis looks like from inside the C-suite

• The current state of pharma’s reputation, including insights from the Gallup poll

• Industry-wide efforts to reshape perception

• How big pharma and smaller biotech firms face different reputational demands

• The surprising connection between reputation and market capitalization

If you’re interested in how pharma companies handle public scrutiny, build trust, and navigate high-stakes issues, this episode is a must-listen.

🎧 Listen now – https://www.ispeboston.org/podcast/episode-33-ray-jordan-and-pharmaceutical-industrys-reputation-and-image/